公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial | Langley R.G.; TSEN-FANG TSAI ; Flavin S.; Song M.; Randazzo B.; Wasfi Y.; Jiang J.; Li S.; Puig L. | British Journal of Dermatology | 261 | 68 | |
2012 | The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection | TSEN-FANG TSAI ; Ho V.; Song M.; Szapary P.; Kato T.; Wasfi Y.; Li S.; Shen Y.K.; Leonardi C. | British Journal of Dermatology | 83 | 64 | |
2019 | Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial | Armstrong A.; Puig L.; Langley R.; TSEN-FANG TSAI ; Song M.; Wasfi Y.; Jiang J.; Li S.; Han C. | Journal of Dermatological Treatment | 18 | 11 |